MerckMEX:MRK +1.86%72 OCF Margin % is 24.06% as of Mar. 2026, which is 7% below its 10-year median of 25.95. GuruFocus rates MEX:MRK with a GF Score™ of 72/100 and a GF Value™ of MXN2,062.64 (Fairly Valued). The stock has 7 warning signs investors should review. Among 959 Drug Manufacturers companies, Merck ranks better than 89.89% on this metric.
OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Merck's Cash Flow from Operations for the
three
months ended in Mar. 2026 was MXN70,652 Mil. Merck's Revenue for the
three
months ended in Mar. 2026 was MXN293,681 Mil. Therefore, Merck's OCF Margin % for the quarter that ended in Mar. 2026 was 24.06%.
The historical rank and industry rank for Merck's OCF Margin % or its related term are showing as below:
MEX:MRK'
s OCF Margin % Range Over the Past 10 Years
Min: 16.08 Med: 25.95 Max: 34.35
Current: 27.24
During the past 13 years, the highest OCF Margin % of Merck was 34.35%. The lowest was 16.08%. And the median was 25.95%.
MEX:MRK's OCF Margin % is ranked better than 89.89% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs MEX:MRK: 27.24
Merck OCF Margin % Related Terms
Merck OCF Margin % Historical Data
* Premium members only.
The historical data trend for Merck's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:MRK vs ABBV, AMGN, GILD: OCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Merck's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Merck's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck (MEX:MRK) has a OCF Margin % of 24.06% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Merck and its competitors. This is near median its historical median of 25.95. Over the past decade, Merck's OCF Margin % has ranged from 16.08 to 34.35. According to the industry distribution chart, Merck ranks #97 out of 959 companies in the Drug Manufacturers industry, placing it in the top 10.1%.
Is Merck's OCF Margin % too high?
Merck's current OCF Margin % of 24.06% is near median its 10-year median of 25.95. Over the past 10 years, this metric has ranged from a low of 16.08 to a high of 34.35. The Drug Manufacturers industry median OCF Margin % is 9.94. Merck's value of 24.06% is 142.1% above this industry median. Based on the distribution chart, Merck ranks #97 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Merck has a GF Score™ of 72/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Merck's OCF Margin % compare to ABBV and AMGN?
According to the Drug Manufacturers industry distribution chart, Merck ranks #97 out of 959 companies for OCF Margin %. This places Merck in the top 10% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Merck's value of 24.06% is 142.1% above this benchmark. Historically, Merck's own OCF Margin % has ranged from 16.08 to 34.35 over the past decade. While the company's 10-year median is 25.95 vs. the industry median of 9.94, Merck has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Merck's current OCF Margin % of 24.06% is 142.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Merck and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Merck's current OCF Margin % is 24.06%, which is near median its own 10-year median of 25.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck stock overvalued right now?
Based on GuruFocus' analysis, Merck (MEX:MRK) is currently considered Fairly Valued. The stock's GF Value™ is MXN2,062.64, compared to a current price of MXN2,241.00 — trading 8.6% above its estimated fair value. The current OCF Margin % is 24.06%, which is near median its 10-year median of 25.95 and 142.1% above the Drug Manufacturers industry median of 9.94. Merck's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Merck (MEX:MRK), the current OCF Margin % is 24.06% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Merck (MEX:MRK) Overvalued in 2026?
Based on GuruFocus' analysis, Merck stock appears to be overvalued.
The current stock price of MXN2,241.00 is trading 8.6% above its estimated GF Value™ of MXN2,062.64.
GuruFocus considers Merck to be Fairly Valued.
Key valuation signals for MEX:MRK:
OCF Margin %: 24.06% (near median its 10-year median of 25.95)
GF Value™: MXN2,062.64 vs. price of MXN2,241.00 (8.6% above fair value)
Industry Position: 142.1% above the Drug Manufacturers median (#97 of 959)
No single metric tells the full story. See the MEX:MRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
72GF Score
Get the complete analysis for MEX:MRK
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:MRK has been successfully added to your 
